Last reviewed: May 30, 2026
Last updated: May 30, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
NAD+ is a coenzyme found in every cell that fuels energy metabolism, DNA repair, and age-related cellular processes. NAD+ levels decline naturally with age, dropping approximately 50% by age 60, which has prompted interest in supplementation to support longevity and metabolic health.
Understanding NAD+ supplementation requires context beyond marketing claims. PlexusDx supports precision wellness by helping patients and providers evaluate whether NAD+ aligns with individual metabolic needs, baseline biomarkers, and genetic predispositions that may influence cellular energy pathways.
How NAD+ Functions in Cellular Energy and Repair
NAD+ exists in two forms: NAD+ (oxidized) and NADH (reduced). This NAD+/NADH ratio is critical for glycolysis, the citric acid cycle, and ATP production—the cell's primary energy currency. NAD+ also activates sirtuins and PARP enzymes that regulate DNA repair, inflammation, and mitochondrial function.
As NAD+ declines, cells lose efficiency in energy production and stress response. Research in model organisms and limited human studies suggests NAD+ restoration may support mitochondrial health, metabolic flexibility, and recovery from cellular stress. However, human clinical evidence remains emerging and inconsistent across populations.
NAD+ Precursors and Supplementation Forms: Clinical Profile
NAD+ supplements are sold as precursors because NAD+ itself is unstable and does not cross the blood-brain barrier effectively. Common precursors include nicotinamide riboside (NR), nicotinamide mononucleotide (NMN), and niacin. Each has different bioavailability, dosing recommendations, and preliminary research support.
| NAD+ Precursor |
Typical Dose |
Bioavailability & Mechanism |
Human Research Status |
| Nicotinamide Riboside (NR) |
250–1000 mg/day |
Enters cells via SLC29A1 transporter; converts to NAD+ intracellularly |
Several small human trials; mixed results on NAD+ elevation and metabolic outcomes |
| Nicotinamide Mononucleotide (NMN) |
250–1000 mg/day |
Enters via SLCO1B3 transporter; direct NAD+ precursor |
Limited human data; primarily animal studies showing promise in aging and glucose tolerance |
| Niacin (Vitamin B3) |
10–500 mg/day |
Precursor via salvage pathway; well-established safety and metabolism |
Extensive evidence; supports energy and cholesterol metabolism but higher doses carry side effects |
| Nicotinamide (Niacinamide) |
250–1000 mg/day |
Direct salvage pathway to NAD+; mild bioavailability |
Long clinical history; modest NAD+ elevation; generally well-tolerated |
Current Clinical Evidence: Realistic Expectations
Most human evidence for NAD+ precursors comes from small, short-term studies. A 2023 systematic review found NR may modestly increase circulating NAD+ levels, but translation to clinical outcomes in healthy adults remains unclear. Larger, longer randomized controlled trials are ongoing.
Specific potential benefits studied include metabolic health, exercise recovery, cognitive function, and cardiovascular resilience. However, effect sizes in humans are modest, variability between individuals is high, and optimal dosing and duration remain undefined. Provider guidance is essential before starting supplementation, particularly for those with pre-existing conditions or medications.
Biomarker Context and Who May Benefit from NAD+ Assessment
NAD+ supplementation decisions benefit from biomarker context. Baseline mitochondrial markers—such as energy substrate utilization, exercise capacity, recovery time, and metabolic flexibility—help providers determine whether NAD+ aligns with individual physiology. Genetic factors influencing NAD+ metabolism and stress-response pathways may also inform personalization.
Not all candidates are appropriate for NAD+ supplementation. Those with mitochondrial dysfunction, age-related metabolic decline, or suboptimal recovery from physical stress may warrant discussion with a provider. Conversely, individuals with normal energy, adequate sleep, and stable metabolic markers may see minimal benefit. A qualified provider can assess your specific context and baseline biomarkers.
How PlexusDx Supports a More Personalized Approach
PlexusDx's Precision Peptide Genetic Test may help provide context by revealing predispositions in genetic pathways that influence cellular metabolism and energy regulation. While the test focuses on peptide and metabolic pathways (including FTO, MC4R, and related variants), understanding your genetic predispositions can support a broader conversation with your provider about whether NAD+ supplementation aligns with your metabolic profile.
Genetic variants do not determine whether NAD+ supplementation will work for you, but they can highlight whether your body naturally favors certain metabolic states or energy utilization patterns. This information, interpreted with a qualified healthcare provider, can help contextualize whether NAD+ restoration is a meaningful intervention for your individual physiology.
If you are considering NAD+ supplementation alongside other precision-wellness strategies, integrating genetic insights with baseline biomarkers creates a more complete picture. Your provider can then evaluate whether NAD+ fits into a personalized plan that also addresses nutrition, metabolic flexibility, and genetic predispositions that influence your cellular health.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $179-$229/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the difference between NAD+, NR, and NMN?
NAD+ is the actual coenzyme; NR and NMN are precursor compounds that cells convert to NAD+. NAD+ itself cannot be taken orally effectively, so supplements use precursors. Each precursor has different absorption routes and research support.
How much does NAD+ naturally decline with age?
Studies suggest NAD+ levels drop approximately 50% by age 60 and continue declining. This decline correlates with reduced mitochondrial efficiency and slower cellular repair, though individual variation is significant.
Does NAD+ supplementation boost energy or workout recovery?
Limited human evidence suggests modest benefits for exercise recovery and mitochondrial function in some populations. Most studies are small and short-term. Individual response varies widely, and a provider should guide supplementation timing and dosing.
Are NAD+ supplements safe? Any side effects?
NAD+ precursors are generally well-tolerated at standard doses. Niacin (high-dose form) can cause flushing and GI upset. NR and NMN have fewer reported side effects in trials. Anyone with liver disease, gout, or taking certain medications should consult a provider before starting.
How does the Precision Peptide Genetic Test relate to NAD+ supplementation?
The test reveals genetic predispositions in metabolic pathways that may influence energy utilization and cellular repair efficiency. While it does not predict NAD+ response directly, insights into your metabolic and stress-response variants can support a more informed conversation with your provider about whether NAD+ fits your wellness strategy.
Related Reading
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
MIC-B12 Injections Reviews Injections: How They Work, Format
NAD+ Online: Clinical Context for Telehealth Access and Biomarker Evaluation